Stacy Chin walks through which SBIR grant pathway to choose: Phase 1, Phase 2, Direct-to-Phase 2, or Fast-Track. The right one depends on your company's development stage and what you're trying to build.
So once you figure out when you'll submit this grant application and whether you want to pursue an SBIR or an STTR, and if you're going to conduct a clinical trial, the next thing to figure out is whether you're going for a Phase I, a Phase II, a Direct-to-Phase II, or a Fast-Track SBIR application. And the answer at its core just comes down to where you currently are in your developments, along with what are your short and long-term goals for your startup.
Applying for NIH SBIR in Jan 5, 2027? You Should Be Starting NOW. Here's why...
How to Get Invited to Apply for $305K in NSF SBIR Funding || Step-by-Step Guide
